Correction
Published on 15 Dec 2025
Correction: Mitochondrial iron overload-mediated inhibition of Nrf2-HO-1/GPX4 assisted ALI-induced nephrotoxicity
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1734058
Type at least 3 characters
718 articles
articles
Editorial
Published on 12 Dec 2025
Editorial: Cell death in kidney diseases: novel biomarkers, mechanisms, and therapeutic strategies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1715728
- 322 views
Correction
Accepted on 11 Dec 2025
Correction: Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway
in Renal Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 11 Dec 2025
THERAPEUTIC TROUGH MYCOPHENOLIC ACID LEVELS POSITIVELY CORRELATE WITH OMEGA-3 FATTY ACIDS IN LEUKOCYTES OF CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME. A PILOT STUDY
in Renal Pharmacology
Frontiers in Pharmacology
Original Research
Accepted on 03 Dec 2025
Impact of Postoperative Flurbiprofen Axetil on Renal Function in Spontaneously Hypertensive Rats
in Renal Pharmacology
Frontiers in Pharmacology
Review
Accepted on 03 Dec 2025
Molecular Mechanisms and Multi-Target Therapeutic Strategies of Diabetic Nephropathy: From Pathogenesis to Precision Interventions
in Renal Pharmacology
Frontiers in Pharmacology
- 154 views
Review
Published on 03 Dec 2025
Advances in ginsenoside treatment for common kidney diseases: pharmacological evaluation and potential mechanisms
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1702234
- 423 views
Original Research
Accepted on 02 Dec 2025
Nanozyme-Armored Natural Enzymes for Acute Kidney Injury Management via Inflammation Regulation and Oxidative Damage Mitigation
in Renal Pharmacology
Frontiers in Pharmacology
Review
Accepted on 30 Nov 2025
Improving kidney transplantation by pharmacological addition of the hypothermic preservation solution: a scoping review
in Renal Pharmacology
Frontiers in Pharmacology
- 167 views
Original Research
Accepted on 24 Nov 2025
High glucose induced PLCG1 histone acetylation to promote ferroptosis by LAMP2A/ HSPA8 in model of Diabetic nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
- 134 views
Review
Accepted on 24 Nov 2025
Unraveling the Role of Mitochondrial Dysfunction in Diabetic Kidney Disease: Insights and Interventions
in Renal Pharmacology
Frontiers in Pharmacology
- 183 views
Review
Published on 21 Nov 2025
Licorice in nephropathy treatment: phytochemical compositions and pharmacological mechanisms
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1672643
- 812 views
Original Research
Published on 19 Nov 2025
Comparative effectiveness and pharmacological fingerprints of indobufen versus rivaroxaban in patients with chronic kidney disease: a single-center, real-world study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1694163
- 572 views
Review
Published on 18 Nov 2025
Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669636
- 739 views
Original Research
Published on 18 Nov 2025
In vivo pharmacokinetic evaluation of molnupiravir in patients with severe chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1696197
- 573 views
Systematic Review
Published on 14 Nov 2025
Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691597
- 799 views
Review
Published on 13 Nov 2025
Immunomodulatory roles of quercetin in diabetic nephropathy: targeting inflammation, oxidative stress, and ferroptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1687677
- 1,209 views
Correction
Published on 12 Nov 2025
Correction: Renoprotective effects of GHRH agonist MR409 is associated with reduced oxidative stress and ferroptosis in diabetic mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737333
- 362 views
Original Research
Published on 12 Nov 2025
Procyanidin displayed a synergistic effect with roxadustat on renal anemia in mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678846
- 1,049 views
Review
Published on 06 Nov 2025
siRNA-mediated therapeutic approaches improve acute kidney injury and limit its worsening
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1697460
- 1,303 views
Original Research
Published on 06 Nov 2025
Development of a venous thromboembolism risk prediction model for patients with primary membranous nephropathy based on machine learning
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1683708
- 950 views
Original Research
Published on 31 Oct 2025
Nafamostat mesilate attenuates renal fibrosis by suppressing the IL-17 signaling pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1648623
- 1,849 views
Original Research
Published on 31 Oct 2025
Clinical efficacy and safety of tripterygium wilfordii glycosides in the treatment of idiopathic membranous nephropathy: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1652789
- 880 views
Correction
Published on 27 Oct 2025
Correction: Astragaloside IV alleviates tacrolimus-induced chronic nephrotoxicity via p62-Keap1-Nrf2 pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1710116
- 570 views